Adalimumab drug aliquots can be used for in vitro or in vivo experiments. For biosimilar development, different batches of Adalimumab drug can be ordered at the same time. Several other reference drugs are also available.
The drug aliquots are generated by aliquoting (dividing and repackaging) the EU-licensed reference drug.